pAC155-pCR8-sgExpression

|Download SnapGene Viewer
Explore Over 2.7k Plasmids: CRISPR Plasmids | More Plasmid Sets
No matches
polIII terminator BbsI (775) BbsI (797) pAC155-pCR8-sgExpression 3178 bp
BbsI  (775)
2 sites
G A A G A C N N C T T C T G N N ( N ) 4

Sticky ends from different BbsI sites may not be compatible.
BbsI gradually loses activity when stored at -20°C.
BbsI  (797)
2 sites
G A A G A C N N C T T C T G N N ( N ) 4

Sticky ends from different BbsI sites may not be compatible.
BbsI gradually loses activity when stored at -20°C.
SmR
1644 .. 2435  =  792 bp
263 amino acids  =  29.3 kDa
Product: aminoglycoside adenylyltransferase (Murphy, 1985)
confers resistance to spectinomycin and streptomycin
SmR
1644 .. 2435  =  792 bp
263 amino acids  =  29.3 kDa
Product: aminoglycoside adenylyltransferase (Murphy, 1985)
confers resistance to spectinomycin and streptomycin
ori
2528 .. 3116  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
2528 .. 3116  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
U6 promoter
798 .. 1046  =  249 bp
RNA polymerase III promoter for human U6 snRNA (Domitrovich & Kunkel, 2003)
U6 promoter
798 .. 1046  =  249 bp
RNA polymerase III promoter for human U6 snRNA (Domitrovich & Kunkel, 2003)
attL1
509 .. 608  =  100 bp
recombination site for the Gateway® LR reaction
attL1
509 .. 608  =  100 bp
recombination site for the Gateway® LR reaction
attL2
1057 .. 1156  =  100 bp
recombination site for the Gateway® LR reaction
attL2
1057 .. 1156  =  100 bp
recombination site for the Gateway® LR reaction
gRNA scaffold
704 .. 779  =  76 bp
guide RNA scaffold for the Streptococcus pyogenes CRISPR/Cas9 system
gRNA scaffold
704 .. 779  =  76 bp
guide RNA scaffold for the Streptococcus pyogenes CRISPR/Cas9 system
rrnB T2 terminator
268 .. 295  =  28 bp
transcription terminator T2 from the E. coli rrnB gene
rrnB T2 terminator
268 .. 295  =  28 bp
transcription terminator T2 from the E. coli rrnB gene
M13 fwd
477 .. 493  =  17 bp
common sequencing primer, one of multiple similar variants
M13 fwd
477 .. 493  =  17 bp
common sequencing primer, one of multiple similar variants
M13 rev
1197 .. 1213  =  17 bp
common sequencing primer, one of multiple similar variants
M13 rev
1197 .. 1213  =  17 bp
common sequencing primer, one of multiple similar variants
polIII terminator
698 .. 703  =  6 bp
RNA polymerase III transcription terminator
polIII terminator
698 .. 703  =  6 bp
RNA polymerase III transcription terminator
ORF:  1425 .. 2435  =  1011 bp
ORF:  336 amino acids  =  37.5 kDa
ORF:  1676 .. 1933  =  258 bp
ORF:  85 amino acids  =  9.1 kDa
ORF:  1943 .. 2221  =  279 bp
ORF:  92 amino acids  =  9.4 kDa
ORF:  394 .. 624  =  231 bp
ORF:  76 amino acids  =  8.6 kDa
ORF:  1683 .. 2066  =  384 bp
ORF:  127 amino acids  =  14.6 kDa
Click here to try SnapGene

Download pAC155-pCR8-sgExpression.dna file

SnapGene

SnapGene is the easiest way to plan, visualize and document your everyday molecular biology procedures

  • Fast accurate construct design for all major molecular cloning techniques
  • Validate sequenced constructs using powerful alignment tools
  • Customize plasmid maps with flexible annotation and visualization controls
  • Automatically generate a rich graphical history of every edit and procedure

SnapGene Viewer

SnapGene Viewer is free software that allows molecular biologists to create, browse, and share richly annotated sequence files.

  • Gain unparalleled visibility of your plasmids, DNA and protein sequences
  • Annotate features on your plasmids using the curated feature database
  • Store, search, and share your sequences, files and maps

Individual Sequences & Maps

The maps, notes, and annotations in the zip file on this page are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as ’’www.snapgene.com/resources’’. Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Discover the most user-friendly molecular biology experience.